乳腺癌患者脑结构连通性与1年意志消沉之间的关联:一项纵向扩散张量成像研究
Associations Between Brain Structural Connectivity and 1-Year Demoralization in Breast Cancer: A Longitudinal Diffusion Tensor Imaging Study.
作者信息
Liang Mu Zi, Chen Peng, Tang Ying, Liang Yu Yan, Li Shu Han, Hu Guang Yun, Sun Zhe, Yu Yuan Liang, Molassiotis Alex, Knobf M Tish, Ye Zeng Jie
机构信息
Guangdong Academy of Population Development, Guangzhou, China.
Basic Medical School, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
出版信息
Depress Anxiety. 2024 Sep 26;2024:5595912. doi: 10.1155/2024/5595912. eCollection 2024.
This study aims to explore the association between brain structural connectivity and 1-year demoralization in patients with newly diagnosed breast cancer. Patients were enrolled from a multicenter longitudinal program named as (BRBC) between 2017 and 2019. Brain structural connectivity was assessed with diffusion tensor imaging (DTI) at baseline and the demoralization scale II collected self-report data at baseline and 1 year later. A data-driven correlational tractography was performed to recognize significant neural pathways associated with the group membership (increased vs. nonincreased demoralization). The incremental prediction values of Quantitative Anisotropy (QA) extracted from the significant white matter tracts against the group membership were evaluated. 21.2% ( = 31) reported increased 1-year demoralization. Inferior fronto-occipital fasciculus (IFOF) was associated with 1-year demoralization in breast cancer. The incremental prediction values of QAs in net reclassification improvement (NRI) and integrated discrimination improvement (IDI) ranged from 8.11% to 46.89% and 9.12% to 23.95%, respectively, over the conventional tumor-nodal metatasis (TNM) staging model. Anisotropy in IFOF is a potential prediction neuromarker to 1-year demoralization in patients with newly diagnosed breast cancer. ClinicalTrials.gov identifier: NCT03026374.
本研究旨在探讨新诊断乳腺癌患者脑结构连通性与1年失志之间的关联。患者于2017年至2019年从一个名为(BRBC)的多中心纵向项目中招募。在基线时用扩散张量成像(DTI)评估脑结构连通性,并在基线和1年后收集失志量表II的自我报告数据。进行了数据驱动的相关纤维束成像,以识别与组群归属(失志增加与未增加)相关的重要神经通路。评估了从重要白质纤维束中提取的定量各向异性(QA)对组群归属的增量预测值。21.2%(n = 31)报告1年失志增加。额枕下束(IFOF)与乳腺癌患者的1年失志相关。与传统的肿瘤-淋巴结转移(TNM)分期模型相比,QA在净重新分类改善(NRI)和综合判别改善(IDI)中的增量预测值分别为8.11%至46.89%和9.12%至23.95%。IFOF中的各向异性是新诊断乳腺癌患者1年失志的潜在预测神经标志物。临床试验.gov标识符:NCT03026374。